NCT07737171Recruiting
Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic Lesions
Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic Lesions: A Pancardinal-4 Prospective Registry
Source: ClinicalTrials.gov · Last updated 30 Jul 2026
Brief summary (registry, in English)
This is a 7-year prospective single-center registry study to assess the safety and efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the treatment of pancreatic lesions.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 27 Jul 2026
- Start date
- 7 Apr 2026
- Primary completion date
- 1 Apr 2033
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Diseases
- Pancreatic cancer
- NCT number
- NCT07737171
What you commit to
- Study type: Observational
- Planned participants: 60
- From 7 Apr 2026 to the primary completion date, 1 Apr 2033
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with co-existing malignancies of other organs (or a prior history of such)
Other
- Patients unable to provide informed consent
- Patients unable to complete follow-up
Who the study is looking for
- Diagnosis of any pancreatic pre-malignant lesion and/or pancreatic malignancy
- Patients already undergoing EUS-RFA for treatment of pancreatic lesions clinically
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The University of Texas Health Science Center at Houston Coordinator of this site? Confirm its status | Houston | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.